Dr. Anna Rosell will be the coordinator of a new H2020 project (EURONANOMED call).
Title: New MAGnetic Biomaterials for Brain Repair and Imaging after Stroke (MAGBBRIS)
According to the World Health Organization, 15 million persons suffer a stroke worldwide each year, and neuro-repair treatments could offer the opportunity to treat stroke patients by extending the therapeutic time window.
By engineering novel magnetic nano-biomaterials we will achieve tissue repair in the context of an ischemic event. We will take advantage of nanotechnology to deliver therapeutic growth factors, secreted by progenitor cells, into the injured brain. MAGBBRIS will demonstrate that growth factors, secreted by endothelial progenitor cells, with proved potential to induce tissue repair, can be encapsulated in magnetic biomaterials and be successfully and safely transplanted into mouse brains with the guidance of magnetic fields, to induce tissue repair.
MAGBBRIS consortium is made up by highly multidisciplinary materials-science, biomedical and clinical research with industrial partnership. The project will provide a new medicinal product ready to be tested in a preclinical multicentric study.
Dr. Anna Rosell, Vall d’Hebron Research Institute. Barcelona, Spain.
Dr. Anna Roig, Agencia Estatal Consejo Superior de Investigaciones Científicas (CSIC). Institut de Ciència de Materials de Barcelona (ICMAB). Bellaterra, Spain.
Dr. Fabien Gosselet, University of Artois, Faculty Jean Perrin. Lens, France.
Dr. Maria Picchio, Ospedale San Raffaele IRCCS. Milano, Italy.
Dr. Filip Jelen, Pure Biologics Ltd. Wrocław, Poland.
Dr. Peter Kopcansky, Institute of experimental physics, Slovak Academy of Sciences, SAS. Kosice, Slovakia.